Ahn-Gook Pharmaceutical안국약품
001540 · KOSDAQ · ₩001540 · 안국약품
₩9,490▼ ₩40 (0.42%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 66.7% | 65.3% | 61.9% | 60.2% | 61.5% | 61.8% |
| Operating margin | 6.9% | 3.2% | 2.5% | 2.2% | 4.7% | −0.7% |
| Net margin | 6.3% | 2.4% | 6.2% | 0.6% | 3.3% | 2.4% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +12.4% | +13.2% | +16.0% | +13.8% | +25.6% | — |
| Operating income growth | +140.9% | +46.6% | +32.4% | −47.7% | +992.5% | — |
| Net income growth | +189.5% | −55.6% | +1,205.7% | −81.2% | +74.5% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 12.6% | 4.5% | 10.6% | 0.8% | 4.5% | 2.6% |
| Return on assets | 6.8% | 2.4% | 6.0% | 0.4% | 3.1% | 1.7% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 84.2% | 87.0% | 83.6% | 57.3% | 44.8% | 43.5% |
| Net debt to equity | 7.0% | 11.1% | −1.5% | −12.0% | −5.1% | −13.2% |
| Current ratio | 168.7% | 164.9% | 174.9% | 173.1% | 198.4% | 222.7% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Ahn-Gook Pharmaceutical / 안국약품 / 001540 / KRX:001540
Source: KRX statistical information